Glutamic Acid

Glutamic Acid

SCHEMBL4396913

N[C@@H](CCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(=O)O.N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 2/20 0.66
SLC7A5 Q01650 1/20 0.54
FOLH1 Q04609 6/20 0.52
ACE P12821 3/20 0.51
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
MME P08473 2/20 0.46
GRM8 O00222 1/20 0.46
GRM6 O15303 1/20 0.46
GRIN2D O15399 1/20 0.46
GRIN3B O60391 1/20 0.46
GSR P00390 1/20 0.46
CYP1A2 P05177 1/20 0.46
GRIK1 P39086 1/20 0.46
GRM5 P41594 1/20 0.46
GRIA1 P42261 1/20 0.46
GRIA2 P42262 1/20 0.46
GRIA3 P42263 1/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL4396908 1.00 NAALAD2 (0.66) NAALAD2SLC7A5FOLH1ACECA1
SCHEMBL159886 0.96 NAALAD2 (0.59) NAALAD2SLC7A5FOLH1ACECA1
SCHEMBL159887 0.96 NAALAD2 (0.59) NAALAD2SLC7A5FOLH1ACECA1
SCHEMBL25409107 0.92 NAALAD2 (0.57) NAALAD2ACEMME
Glutamic Acid SCHEMBL4387195 0.90 NAALAD2 (0.64) NAALAD2SLC7A5FOLH1ACEMME
D-Glutamate SCHEMBL4387193 0.90 NAALAD2 (0.64) NAALAD2SLC7A5FOLH1ACEMME
Acetyl Tyrosine SCHEMBL21436109 0.89 NAALAD2 (0.64) NAALAD2SLC7A5FOLH1ACECA1
SCHEMBL15345875 0.88 FOLH1 (0.67) NAALAD2SLC7A5FOLH1ACEMME
SCHEMBL159463 0.87 NAALAD2 (0.69) NAALAD2SLC7A5FOLH1ACEMME
SCHEMBL159464 0.87 NAALAD2 (0.69) NAALAD2SLC7A5FOLH1ACEMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10175233-B2 Biomarkers for cardiovascular diseases and methods using the same METABOLON, INC. (US) 2019-01-08 US disclosed
US-20160178620-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2016-06-23 US disclosed
US-9250225-B2 Biomarkers for insulin resistance and methods using the same METABOLON, INC. (US) 2016-02-02 US disclosed
US-20150005195-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2015-01-01 US disclosed
US-8809008-B2 Biomarkers for impaired glucose tolerance and methods using the same METABOLON, INC. (US) 2014-08-19 US disclosed
US-20130338031-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. 2013-12-19 US disclosed
EP-2164977-B1 BIOMARKERS FOR PRE-DIABETES AND METHODS USING THE SAME METABOLON INC (US) 2013-10-30 EP disclosed
US-8546098-B2 Biomarkers for monitoring insulin resistance and methods using the same METABOLON, INC. (US) 2013-10-01 US disclosed
US-20120208215-A1 Biomarkers for Pre-Diabetes, Cardiovascular Diseases, and Other Metabolic-Syndrome Related Disorders and Methods Using the Same METABOLON, INC. (US) 2012-08-16 US disclosed
US-8187830-B2 Method for determining insulin sensitivity with biomarkers METABOLON, INC. (US) 2012-05-29 US disclosed
US-20090155826-A1 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same METABOLON, INC. (US) 2009-06-18 US disclosed